Literature DB >> 22273509

The platelet P2Y12 receptor contributes to granule secretion through Ephrin A4 receptor.

Erik Tournoij1, C Arnold Koekman, Vivian X Du, Mark Roest, Rob Ruijtenbeek, Frans L Moll, Jan-Willem N Akkerman.   

Abstract

The main responses of P2Y(1) ligation are platelet shape change and transient aggregation while P2Y(12) ligation amplifies P2Y(1)-induced aggregation and accelerates aggregation, secretion and thromboxane A(2) production induced by other agonist-receptor complexes. We searched for new targets of P2Y signalling using micro-arrays with 144 peptides representing known phosphosites of protein tyrosine kinases. ADP induced phosphorylation of peptides representing surface receptors, second messenger enzymes and cytoskeletal proteins. Strong phosphorylation was found in peptides representing Ephrin-receptor family members. Blockade of P2Y(1/12) inhibited phosphorylation of EphA4- and EphB1-peptides on micro-arrays. The EphA2/4 inhibitor 2,5-dimethylpyrrolyl benzoic acid derivative interfered with P2Y(1/12)-induced EphA4 phosphorylation, left P2Y(1)-induced aggregation unchanged but inhibited with P2Y(12)-induced secretion, second phase aggregation and thrombus formation on collagen at 1600 s(-1). These results show that platelet EphA4 is an important intermediate in P2Y(12)-induced granule secretion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22273509     DOI: 10.3109/09537104.2011.645924

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  5 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

2.  On the use of 2,5-dimethyl-pyrrol-1-yl-benzoic acid derivatives as EPH-ephrin antagonists.

Authors:  Alessio Lodola; Matteo Incerti; Massimiliano Tognolini
Journal:  J Virol       Date:  2014-10       Impact factor: 5.103

3.  Reply to "On the use of 2,5-dimethyl-pyrrol-1-yl-benzoic acid derivatives as EPH-ephrin antagonists".

Authors:  Ronald C Desrosiers; Alexander S Hahn
Journal:  J Virol       Date:  2014-10       Impact factor: 5.103

4.  Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer's disease correlates with pathology.

Authors:  Andrea Fn Rosenberger; Annemieke Jm Rozemuller; Wiesje M van der Flier; Philip Scheltens; Saskia M van der Vies; Jeroen Jm Hoozemans
Journal:  Acta Neuropathol Commun       Date:  2014-07-16       Impact factor: 7.801

Review 5.  Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity.

Authors:  Thayer K Darling; Tracey J Lamb
Journal:  Front Immunol       Date:  2019-07-04       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.